Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintaining remifentanil infusion until extubation in supratentorial craniotomy
IRCT2012110711398N1Phase 3Completed
- Sponsor
- Research Deputy, TUMS School of Medicine
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remifentanil in supratentorial brain lesion, sponsored by Research Deputy, TUMS School of Medicine. Started Aug 2012; status: completed.
02
Drugs
remifentanil
03
Conditions
supratentorial brain lesion
Beyond the preview
Go deeper on IRCT2012110711398N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012110711398N1.